TrialClinical endocrinology2017

A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin.

Naris Nilubol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.